CD10 is widely used to distinguish most cases of ALL from other hematologic malignancies, and is commonly used in diagnosis via flow cytometry and monitoring of hematologic malignancies of B cell origin, in the categorization of the mature and blastic stage, and also for detection of measurable residual disease (50, 51). This evidence concerns the gene MME and acute lymphoblastic leukemia.